{"id":13565,"date":"2013-05-20T00:00:33","date_gmt":"2013-05-19T22:00:33","guid":{"rendered":"http:\/\/alcyon:7777\/transgene170914\/?p=13565"},"modified":"2025-11-12T16:54:29","modified_gmt":"2025-11-12T15:54:29","slug":"phase-ib-dose-escalation-study-of-pexa-vec-pexastimogene-devacirepvec-jx-594-an-oncolytic-and-immunotherapeutic-vaccinia-virus-administered-by-intravenous-iv-infusions-in-patients-with-metastat-2","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/phase-ib-dose-escalation-study-of-pexa-vec-pexastimogene-devacirepvec-jx-594-an-oncolytic-and-immunotherapeutic-vaccinia-virus-administered-by-intravenous-iv-infusions-in-patients-with-metastat-2\/","title":{"rendered":"Phase Ib dose-escalation study of Pexa-Vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, administered by intravenous (IV) infusions in patients with metastatic colorectal carcinoma (mCRC)"},"content":{"rendered":"<p><a href=\"http:\/\/meeting.ascopubs.org\/cgi\/content\/abstract\/31\/15_suppl\/3608?sid=e16b8da1-8ce1-4b77-8ecd-372140abfe94\">link<\/a><br \/>\nJ. Lee J, S.Y. Park, J. Burke, H.Y. Lim, J. Lee, W.K. Kang, J.O. Park, A. Pelusio, C. Breitbach, D.H. Kirn<br \/>\n<em>Journal of clinical Oncology, 2013, 31, (suppl; abstr 3608)<\/em><br \/>\n<span style=\"display:block\">[Publication]<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>link J. Lee J, S.Y. Park, J. Burke, H.Y. Lim, J. Lee, W.K. Kang, J.O. Park, A. Pelusio, C. Breitbach, D.H. Kirn Journal of clinical Oncology, 2013, 31, (suppl; abstr 3608) [Publication]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,148,1,5],"tags":[],"class_list":["post-13565","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-148","category-non-classifiee","category-publication-fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"link J. Lee J, S.Y. Park, J. Burke, H.Y. Lim, J. Lee, W.K. Kang, J.O. Park, A. Pelusio, C. Breitbach, D.H. Kirn Journal of clinical Oncology, 2013, 31, (suppl; abstr 3608) [Publication]","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/13565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=13565"}],"version-history":[{"count":2,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/13565\/revisions"}],"predecessor-version":[{"id":38831,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/13565\/revisions\/38831"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=13565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=13565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=13565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}